Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q390709> ?p ?o }
Showing triples 1 to 19 of
19
with 100 triples per page.
- Q390709 subject Q8413416.
- Q390709 abstract "A endothelin receptor antagonist (ERA) is a drug that blocks endothelin receptors. Three main kinds of ERAs exist: selective ETA receptor antagonists (sitaxentan, ambrisentan, atrasentan, BQ-123, zibotentan), which affect endothelin A receptors. dual antagonists (bosentan, macitentan, tezosentan), which affect both endothelin A and B receptors. selective ETB receptor antagonists (BQ-788 and A192621) which affect endothelin B receptors are used in research but have not yet reached the clinical trial stage.Sitaxentan, ambrisentan and bosentan are mainly used for the treatment of pulmonary arterial hypertension, while atrasentan is an experimental anti-cancer drug.".
- Q390709 wikiPageWikiLink Q1128595.
- Q390709 wikiPageWikiLink Q12078.
- Q390709 wikiPageWikiLink Q12140.
- Q390709 wikiPageWikiLink Q125083.
- Q390709 wikiPageWikiLink Q18023163.
- Q390709 wikiPageWikiLink Q18023174.
- Q390709 wikiPageWikiLink Q198371.
- Q390709 wikiPageWikiLink Q390537.
- Q390709 wikiPageWikiLink Q410789.
- Q390709 wikiPageWikiLink Q419769.
- Q390709 wikiPageWikiLink Q426203.
- Q390709 wikiPageWikiLink Q4836304.
- Q390709 wikiPageWikiLink Q6724151.
- Q390709 wikiPageWikiLink Q8413416.
- Q390709 wikiPageWikiLink Q905664.
- Q390709 comment "A endothelin receptor antagonist (ERA) is a drug that blocks endothelin receptors. Three main kinds of ERAs exist: selective ETA receptor antagonists (sitaxentan, ambrisentan, atrasentan, BQ-123, zibotentan), which affect endothelin A receptors. dual antagonists (bosentan, macitentan, tezosentan), which affect both endothelin A and B receptors.".
- Q390709 label "Endothelin receptor antagonist".